Padhani Anwar R, Ah-See Mei-Lin W, Makris Andreas
Mount Vernon Hospital, Paul Strickland Scanner Centre, Rickmansworth Road, Northwood, Middlesex HA6 2RN, UK.
Expert Rev Anticancer Ther. 2005 Apr;5(2):239-52. doi: 10.1586/14737140.5.2.239.
Breast magnetic resonance imaging (MRI) is now at a stage where the evidence is suggesting widespread potential in the management of patients with known or suspected breast cancers. MRI is used as a supplementary tool to complement conventional methods of breast evaluation because it has excellent problem-solving capabilities. Many indications for clinical breast MRI are recognized, including resolving findings on mammography, staging of breast cancer when multiple or bilateral disease is suspected, and detecting the occult primary breast cancer presenting with malignant axillary lymphadenopathy but no detectable lesion on conventional breast examination. There is also encouraging ongoing research evaluating its role for the assessment of patients at high risk of breast cancer, for primary staging of cancers in radiographically dense breasts and for the assessment of response to chemotherapy. This article will review both the technical aspects of performing and interpreting breast MRI, as well as the current and possible future roles of breast MRI, comparing its strengths and weaknesses with conventional imaging.
乳腺磁共振成像(MRI)目前正处于这样一个阶段:有证据表明,它在已知或疑似乳腺癌患者的管理中具有广泛的潜在应用价值。MRI被用作补充工具,以补充传统的乳腺评估方法,因为它具有出色的问题解决能力。临床乳腺MRI的许多适应证已得到认可,包括解决乳腺X线摄影的检查结果、在怀疑有多发性或双侧性疾病时对乳腺癌进行分期,以及检测以腋窝恶性淋巴结病为表现但在传统乳腺检查中未发现可检测病变的隐匿性原发性乳腺癌。目前也有令人鼓舞的正在进行的研究,评估其在评估乳腺癌高危患者、对乳腺X线摄影显示致密型乳腺中的癌症进行初始分期以及评估化疗反应方面的作用。本文将回顾乳腺MRI检查和解读的技术方面,以及乳腺MRI目前和未来可能的作用,并将其与传统成像的优缺点进行比较。